Skip to content
OpenCapital
Get started

Adial Pharmaceuticals ADIL Q3 2025 earnings

Reported November 13, 2025 · Before market open

EPS-$2.00Beat by $0.25
EPS estimate-$2.25

Next report

Aug 12, 2026 (In 1 week)
EPS estimate-$1.02

Versus estimates

Diluted EPS

Q1 2026-$1.48Beat by $1.25Q4 2025-$1.81Beat by $0.29
Q3 2025-$2.00Beat by $0.25
Q2 2025-$0.18Beat by $0.04Q1 2025-$0.34Beat by $0.16Q4 2024-$0.15Beat by $0.23

Ask the moment Adial Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Adial Pharmaceuticals report Q3 2025 earnings?
Adial Pharmaceuticals (ADIL) reported Q3 2025 earnings on November 13, 2025 before market open.
What were Adial Pharmaceuticals's Q3 2025 revenue and EPS?
Adial Pharmaceuticals reported eps of $-2.00 for Q3 2025.
Did Adial Pharmaceuticals beat estimates in Q3 2025?
EPS beat the consensus estimate of $-2.25 by $0.25.
How did Adial Pharmaceuticals's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 426.3% from $-0.38.
Where can I find Adial Pharmaceuticals's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001213900-25-110385) and the 10-Q periodic report (0001213900-25-109979) directly on SEC EDGAR. The filing index links above go to sec.gov.